Background and Update for S1602 “A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-naïve High-grade Non-muscle-invasive Bladder Cancer

Background and Update for S1602 “A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-naïve High-grade Non-muscle-invasive Bladder Cancer

Guardado en:
Detalles Bibliográficos
Autores principales: Robert S. Svatek, Cathy Tangen, Scott E. Delacroix, William T. Lowrance, Seth P. Lerner
Formato: Artigo
Lenguaje:inglés
Publicado: 2018
Acceso en línea:https://doi.org/10.1016/j.euf.2018.08.015
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doi.org/10.1016/j.euf.2018.08.015

Ejemplares similares